Soleno Therapeutics board changes: Chairman Mario resigns for health; Dawn Bir appointed as director

SOLENO THERAPEUTICS INC

Chairman Ernest Mario resigns effective August 15, 2024 for health reasons; no disagreement with company.
Dawn Carter Bir appointed to board effective August 15, 2024; receives 13,000 RSUs vesting over 3 years.
Matthew Pauls named Lead Independent Director; Andrew Sinclair chairs Compensation Committee.
Bir brings over 30 years biotech experience, led commercial launches at Reata and Pharmacyclics.

item 5.02 item 8.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Dawn C. Bir

Director

SLNO · SOLENO THERAPEUTICS INC

Effective: 2024-08-15
Filed: August 15, 2024, 7:59 PM ET

On August 13, 2024, the Board appointed Dawn C. Bir to the Board effective upon Dr. Mario’s retirement on August 15, 2024.

Departed

Ernest Mario

Chairman of the Board

SLNO · SOLENO THERAPEUTICS INC

Effective: 2024-08-15
Successor: Dawn C. Bir
Filed: August 15, 2024, 7:59 PM ET

On August 9, 2024, Dr. Ernest Mario, the Chairman of the Board of Directors (the “Board”) of Soleno Therapeutics, Inc. (the “Company”), notified the Company that he intended to resign from the Board for health reasons effective as of August 15, 2024.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Dawn C. Bir was appointed as Director at SOLENO THERAPEUTICS INC.

Action: appointed
Role: Director

Exact text from the filing

On August 13, 2024, the Board appointed Dawn C. Bir to the Board effective upon Dr. Mario’s retirement on August 15, 2024.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Ernest Mario resigned as Chairman of the Board at SOLENO THERAPEUTICS INC.

Action: resigned
Role: Chairman of the Board

Exact text from the filing

On August 9, 2024, Dr. Ernest Mario, the Chairman of the Board of Directors (the “Board”) of Soleno Therapeutics, Inc. (the “Company”), notified the Company that he intended to resign from the Board for health reasons effective as of August 15, 2024.

View on SEC.gov

SOLENO THERAPEUTICS INC filing history →

Source: SEC EDGAR

accession 0001193125-24-201313

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.